Press releaseGlobe Newswire
Can Fite Biopharma
CANF · TEL
$1.78−$0.05 (−2.73%)TodayMarket closed ·
Prev close $1.83
Latest news
- Press releaseGlobe Newswire
Can-Fite Reports Q2 2026 Financial Results and Ongoing Clinical Progress Highlighting Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study
- NewsVandana Singh
Can-Fite BioPharma Evaluates Earlier Interim Analysis for Key Liver Cancer Study
- Press releaseGlobe Newswire
Can-Fite Announces Exercise of Warrants for Approximately $4.0 Million in Gross Proceeds
- News
Can-Fite Says Blinded Overall Survival Observed Across Entire Patient Population In Ongoing Pivotal Phase III Study Of Namodenoson In Advanced HCC Appears Longer Than Originally Anticipated Based On Assumptions Underlying Study Design
- Press releaseGlobe Newswire
Can-Fite Reports Longer-Than-Anticipated Overall Survival in Ongoing Pivotal Phase III Liver Cancer Study
- Press releaseGlobe Newswire
Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic Cancer
- Press releaseGlobe Newswire
Can-Fite Highlights Advanced FDA and EMA Regulatory Status of its Phase III Drug Candidates
- News
Can-Fite BioPharma Submits Phase 2 Clinical Study Protocol To Bambino Gesù Children's Hospital In Rome, Italy, For First Clinical Evaluation Of Piclidenoson In Patients With Lowe Syndrome
- Press releaseGlobe Newswire
Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome
- Press releaseGlobe Newswire
Can-Fite Positive Phase 2a Pancreatic Cancer Study Data Accepted for Presentation at ESMO Congress 2026, One of the World's Premier Scientific Meetings in Oncology
- NewsVandana Singh
Can-Fite Highlights Survival Outcomes In Pancreatic Cancer Patients
- News
Market-Moving News for July 1st
- NewsAkanksha Bakshi
Can-Fite Stock Jumps After Japan Patent Boosts Obesity Drug Case
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
Market-Moving News for June 26th
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsAvi Kapoor
Nasdaq Surges Over 1%; ISM Services PMI Tops Views
- NewsAvi Kapoor
Dow Surges 100 Points; Abercrombie & Fitch Shares Fall After Q4 Results
- News
Market-Moving News for March 4th
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- NewsAvi Kapoor
Nasdaq Down 1%; Medtronic Earnings Top Views
- NewsAvi Kapoor
Dow Falls Over 300 Points; Home Depot Posts Downbeat Earnings
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
Can-Fite Biopharma Shares Halted On Code News Pending
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.